Sunitinib Sandoz 50 mg, harde capsules

국가: 네덜란드

언어: 네덜란드어

출처: CBG-MEB (College ter Beoordeling van Geneesmiddelen)

유효 성분:

SUNITINIB 50 mg/stuk

제공처:

Sandoz B.V. Veluwezoom 22 1327 AH ALMERE

ATC 코드:

L01XE04

INN (International Name):

SUNITINIB 50 mg/stuk

약제 형태:

Capsule, hard

구성:

CELLULOSE, MICROKRISTALLIJN (E 460(i)) ; CROSCARMELLOSE NATRIUM (E 468) ; GELATINE (E 441) ; IJZEROXIDE GEEL (E 172) ; IJZEROXIDE ROOD (E 172) ; IJZEROXIDE ZWART (E 172) ; MAGNESIUMSTEARAAT (E 470b) ; MANNITOL (D-) (E 421) ; POVIDON K 30 (E 1201) ; PROPYLEENGLYCOL (E 1520) ; SCHELLAK (E 904) ; TITAANDIOXIDE (E 171) ; WITTE INKT, CELLULOSE, MICROKRISTALLIJN (E 460) ; CROSCARMELLOSE NATRIUM (E 468) ; GELATINE (E 441) ; IJZEROXIDE GEEL (E 172) ; IJZEROXIDE ROOD (E 172) ; IJZEROXIDE ZWART (E 172) ; MAGNESIUMSTEARAAT (E 470b) ; MANNITOL (D-) (E 421) ; POVIDON K 30 (E 1201) ; PROPYLEENGLYCOL (E 1520) ; SCHELLAK (E 904) ; TITAANDIOXIDE (E 171) ; WITTE INKT

관리 경로:

Oraal gebruik

치료 영역:

Sunitinib

승인 날짜:

1900-01-01

환자 정보 전단

Sandoz B.V.
Page 1/15
Sunitinib Sandoz 12,5 / 25 /37,5 /50 mg, harde capsules
V2
RVG 122367-8-9-70
1.3.1.3 Bijsluiter
September 2019
PACKAGE LEAFLET: INFORMATION FOR THE USER
SUNITINIB SANDOZ 12,5 MG, HARDE CAPSULES
SUNITINIB SANDOZ 25 MG, HARDE CAPSULES
SUNITINIB SANDOZ 37,5, MG HARDE CAPSULES
SUNITINIB SANDOZ 50 MG, HARDE CAPSULES
sunitinib
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm
them, even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What is and what it is used for
2.
What you need to know before you take
3.
How to take
4.
Possible side effects
5.
How to store
6.
Contents of the pack and other information
1.
WHAT IS AND WHAT IT IS USED FOR
contains the active substance sunitinib, which is a
protein kinase inhibitor. It
is used to treat cancer by preventing the activity of a special group
of proteins which are
known to be involved in the growth and spread of cancer cells.
is used to treat adults with the following types of
cancer:
-
Gastrointestinal stromal tumour (GIST), a type of cancer of the
stomach and bowel,
where imatinib (another anticancer medicine) no longer works or you
cannot take
imatinib.
-
Metastatic renal cell carcinoma (MRCC), a type of kidney cancer that
has spread to
other parts of the body.
-
Pancreatic neuroendocrine tumours (pNET) (tumours of the
hormone-producing cells in
the pancreas) that have progressed or cannot be removed with surgery.
If you have any questions about how works or why this
medicine ha

제품 특성 요약

Sandoz B.V.
Page 1/34
Sunitinib Sandoz 12,5 / 25 /37,5 /50 mg, harde capsules
v5
RVG 122367-8-9-70
1.3.1.1 Samenvatting van de Productkenmerken
Januari 2024
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Sunitinib Sandoz 12,5 mg, harde capsules
Sunitinib Sandoz 25 mg, harde capsules
Sunitinib Sandoz 37,5, mg harde capsules
Sunitinib Sandoz 50 mg, harde capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
12.5 mg hard capsules
Each capsule contains 12.5 mg of sunitinib.
Excipient with known effect:
Each capsule contains 0.42 mg of sodium.
25 mg hard capsules
Each capsule contains 25 mg of sunitinib.
Excipient with known effect:
Each capsule contains 0.84 mg of sodium.
37.5 mg hard capsules
Each capsule contains 37.5 mg of sunitinib.
Excipient with known effect:
Each capsule contains 1.26 mg of sodium.
50 mg hard capsules
Each capsule contains 50 mg of sunitinib.
Excipient with known effect:
Each capsule contains 1.68 mg of sodium.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Hard capsule (capsule).
12.5 mg hard capsules (capsules)
Gelatin capsules of size 4 with orange cap and orange body, printed
with white ink “12.5 mg”
on the body and containing yellow to orange granules.
Sandoz B.V.
Page 2/34
Sunitinib Sandoz 12,5 / 25 /37,5 /50 mg, harde capsules
v5
RVG 122367-8-9-70
1.3.1.1 Samenvatting van de Productkenmerken
Januari 2024
25 mg hard capsules (capsules)
Gelatin capsules of size 3 with caramel cap and orange body, printed
with white ink “25 mg”
on the body and containing yellow to orange granules.
37.5 mg hard capsules (capsules)
Gelatin capsules of size 2 with yellow cap and yellow body, printed
with black ink “37.5 mg”
on the body and containing yellow to orange granules.
50 mg hard capsules (capsules)
Gelatin capsules of size 1 with caramel cap and caramel body, printed
with white ink “50 mg”
on the body and containing yello